| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/04/2006 | EP1150681B1 Use of a pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
| 01/04/2006 | EP1102755B1 Substituted isoxazole derivatives as estrogen receptor modulators |
| 01/04/2006 | EP1083898B1 Novel use of hiv protease inhibiting compounds |
| 01/04/2006 | EP1070083B1 Crystalline forms of 1s- [1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- [[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino [1, 2-a][ 1,2] diazepine-1-carboxamide |
| 01/04/2006 | EP0977562B1 Methods and compositions for delivery of taxanes |
| 01/04/2006 | EP0934288B1 Oxadiazoles, processes for their preparation and their use as medicaments |
| 01/04/2006 | CN1717497A Treatment of huntington's disease with EPA |
| 01/04/2006 | CN1717391A Inhibitors of glycogen synthase kinase 3 |
| 01/04/2006 | CN1717390A Piperazine and piperidine derivatives for treatment of neurological diseases |
| 01/04/2006 | CN1717321A Multilaminate backing construction |
| 01/04/2006 | CN1717250A Anti-cancer and anti-infectious disease compositions and methods for using same |
| 01/04/2006 | CN1717245A Medicinal composition |
| 01/04/2006 | CN1717241A Use of enteric glia to promote functional nerve connections |
| 01/04/2006 | CN1717237A Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
| 01/04/2006 | CN1717235A Method of treating movement disorders using barbituric acid derivatives |
| 01/04/2006 | CN1717229A Composition and its use for treating neuropathic sensory loss |
| 01/04/2006 | CN1717228A Pharmaceutical composition comprising a LTB4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 01/04/2006 | CN1715294A Endomorphin analog and its preparing method |
| 01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
| 01/04/2006 | CN1715279A Repinotan analogue,its preparing method and use |
| 01/04/2006 | CN1714867A Triacetin as a transdermal penetration enhancer |
| 01/04/2006 | CN1714857A Use of medicinal composition containing pilose antler for treating chronic brain blood supply deficiency |
| 01/04/2006 | CN1714832A Medicinal composition with synergetic function |
| 01/04/2006 | CN1714811A Radix bupleuri dripping pill and its preparing method |
| 01/04/2006 | CN1714797A Medicinal use of paeoniflorin |
| 01/04/2006 | CN1714791A Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 01/04/2006 | CN1714787A Tromethamine gel form medicinal composition |
| 01/04/2006 | CN1234708C Novel imidazotriazinones and the use thereof |
| 01/04/2006 | CN1234702C Benzopyran compound, and pharmaceutical composition including them |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234414C Drugs for complications of diabetes and neuropathy and utilization thereof |
| 01/04/2006 | CN1234410C Brain protein hydrolysate freeze-drying powder injection and its preparing method |
| 01/04/2006 | CN1234409C Combination of medication for treating depression and preparation method |
| 01/04/2006 | CN1234401C Bi-ant contained dampness dispelling and collaterals dredging medicinal capsule |
| 01/04/2006 | CN1234385C Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia |
| 01/04/2006 | CN1234367C Arylazo-substituted imidazole for treatment of stress urinary incontinence |
| 01/04/2006 | CN1234362C Opioid agonist/antagonist combinations |
| 01/04/2006 | CN1234361C Method for preparing medicine of levo-stephandinine |
| 01/04/2006 | CN1234360C Complementary gain pain-killing medicine |
| 01/04/2006 | CN1234358C Benzothiazole derivatives |
| 01/04/2006 | CN1234357C Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/04/2006 | CN1234352C Treatment of PCP addiction and PCP addiction-related behavior |
| 01/04/2006 | CN1234351C Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use |
| 01/03/2006 | US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 01/03/2006 | US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function |
| 01/03/2006 | US6982277 Antitumor agents, antiinflammatory agents; for example 2-(2-imino-4,5,6,7-tetrahydro-1,3-benzothiazol-3(2H)-yl)-1-(4-methylphenyl) -1-ethanone, 2-(4-methylphenyl)-5,6,7,8-tetrahydrobenzo(d)-imidazo(2,1-b)thiazole |
| 01/03/2006 | US6982274 excellent inhibitory action on protein phosphatase (protein kinase), especially on JNK protein kinase; therapeutic or prophylactic agents for immunologic disease, inflammatory disease and/or neurodegenerative disease |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982271 selective norepinephrine and serotonin reuptake inhibitor (SSNRI); antidepressant; treating cocaine addiction; "N3 bridged" tropanes |
| 01/03/2006 | US6982269 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 01/03/2006 | US6982264 Enzyme inhibitors of beta-secretase-mediated cleavage of amyloid precuror proteins; congnition activators; Down's syndrome; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; Parkinson's disease; hemostatic agents |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982262 Combination of cyamemazine and an atypical neuroleptic |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | US6982084 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2264901C Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 01/03/2006 | CA2244773C Tropane-derivatives, their preparation and use |
| 01/03/2006 | CA2235747C Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis |
| 01/03/2006 | CA2132297C Pyrido[2,3-d]pyrimidine derivatives as phosphodiesterase inhibitors |
| 12/30/2005 | CA2510985A1 Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction and processes for obtaining the same |
| 12/29/2005 | WO2005123775A1 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 12/29/2005 | WO2005123741A1 Alkyl substituted indoloquinoxalines |
| 12/29/2005 | WO2005123735A1 Process for producing evodiamine-containing composition |
| 12/29/2005 | WO2005123732A1 1-aza-bicyclo[3.3.1]nonanes |
| 12/29/2005 | WO2005123718A2 Benzimidazolone carboxylic acid derivatives |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123681A1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 12/29/2005 | WO2005123679A2 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | WO2005123081A2 (2-benzyl-4-{4-[1-(tetrahydrofuran-3-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-piperidin-1-yl)-(3,5-trifluoromethyl-phenyl))-methanone for the treatment of schizophrenia |
| 12/29/2005 | WO2005123068A2 Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor |
| 12/29/2005 | WO2005105995A3 RNA INTERFERENCE MEDIATED TREATMENT OF POLYGLUTAMINE (POLYQ) REPEAT EXPANSION DISEASES USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/29/2005 | WO2005096717A3 Agent exhibiting hepatoprotective properties |
| 12/29/2005 | WO2005000203A3 Methods for treating cognitive impairment and improving cognition |
| 12/29/2005 | WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050289658 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 12/29/2005 | US20050289657 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288368 Compositions and methods for treating and preventing necrosis |
| 12/29/2005 | US20050288366 Administering N-(4-carboxybutyl)-N-(p-carboxybenzyl)-benzyl- or phenethyl-amine derivatives: 4-({(4-Carboxybutyl)[3-(4-cyclohexylphenoxy)benzyl]amino}methyl)-benzoic acid; stimulate soluble guanylate cyclase also via a novel mechanism of action which takes place without involvement of the heme group |
| 12/29/2005 | US20050288363 Therapeutic compositions and methods of use |
| 12/29/2005 | US20050288359 Agents and methods for the treatment of disorders associated with oxidative stress |
| 12/29/2005 | US20050288358 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288356 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 12/29/2005 | US20050288355 Combination therapy wherein a serotonin reuptake inhibitor is used |
| 12/29/2005 | US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 12/29/2005 | US20050288351 Azaspiro compounds for the treatment of pain |
| 12/29/2005 | US20050288346 Acetophenone potentiators of metabotropic glutamate receptors |
| 12/29/2005 | US20050288344 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 12/29/2005 | US20050288342 For therapy of pain |
| 12/29/2005 | US20050288340 Substituted heteroaryl- and phenylsulfamoyl compounds |